Intermittent hepatic inflow occlusion during partial hepatectomy for hepatocellular carcinoma does not shorten overall survival or increase the likelihood of tumor recurrence

Medicine (United States)

Volumn 93, Issue 28, 2014, Pages e288-

  Huang, Jiwei ^a   Tang, Wei ^b   Hernandez Alejandro, Roberto ^c   Bertens, Kimberly A ^c   Wu, Hong ^a   Liao, Mingheng ^a   Li, Jiaxin ^a   Zeng, Yong ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ACUTE LIVER FAILURE; ADULT; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BILE DUCT FISTULA; BLOOD COMPONENT THERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHEST INFECTION; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HYDROTHORAX; INTERMITENT HEPATIC INFLOW OCCLUSION; INTESTINE OBSTRUCTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSTRUCTIVE JAUNDICE; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; STOMACH HEMORRHAGE; STOMACH PERFORATION; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING; BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; CHINA; EPIDEMIOLOGY; HEMOSTASIS; HEPATIC ARTERY; INTRAOPERATIVE PERIOD; LIVER; LIVER CIRCULATION; LIVER NEOPLASMS; LIVER RESECTION; LIVER VEIN; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; VASCULARIZATION;

BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; CHINA; FEMALE; FOLLOW-UP STUDIES; HEMOSTASIS, SURGICAL; HEPATECTOMY; HEPATIC ARTERY; HEPATIC VEINS; HUMANS; INTRAOPERATIVE PERIOD; LIVER; LIVER CIRCULATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84920146654     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000288     Document Type: Article

References (54)

1. Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010; 252: 903-912.
2. Huang J, Hernandez-Alejandro R, Croome KP, et al. Hepatic resection for huge (>15 cm) multinodular HCC with macrovascular invasion. J Surg Res. 2012; 178: 743-750.
3. Sugawara Y, Kokudo N. Surgical treatment of hepatocellular carcinoma: comparison of resection and transplantation. Oncology. 2008; 75(Suppl 1): 119-123.
4. Yamamoto J, Kosuge T, Saiura A, et al. Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria. Jpn J Clin Oncol. 2007; 37: 287-295.
5. Song P, Tang W, Tamura S, et al. The management of hepatocellular carcinoma in Asia: a guideline combining quantitative and qualitative evaluation. Biosci Trends. 2010; 4: 283-287.
6. Fortner JG, Blumgart LH. A historic perspective of liver surgery for tumors at the end of the millennium. J Am Coll Surg. 2001; 193: 210-222.
7. Huntington JT, Royall NA, Schmidt CR. Minimizing blood loss during hepatectomy: a literature review. J Surg Oncol. 2014; 109: 81-88.
8. Sakamoto Y, Makuuchi M, Takayama T, et al. Pringle's maneuver lasting 322 min. Hepatogastroenterology. 1999; 46: 457-458.
9. Imamura H, Takayama T, Sugawara Y, et al. Pringle's manoeuvre in living donors. Lancet. 2002; 360: 2049-2050.
10. Pringle JHV. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908; 48: 541-549.
11. Man K, Fan ST, Ng IO, et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg. 1997; 226: 704-711.
12. Buell JF, Koffron A, Yoshida A, et al. Is any method of vascular control superior in hepatic resection of metastatic cancers? Longmire clamping, Pringle maneuver, and total vascular isolation. Arch Surg. 2001; 136: 569-575.
13. Figueras J, Llado L, Ruiz D, et al. Complete versus selective portal triad clamping for minor liver resections: a prospective randomized trial. Ann Surg. 2005; 241: 582-590.
14. Kim YI, Fujita S, Hwang YJ, et al. Successful intermittent application of the Pringle maneuver for 30 minutes during human hepatectomy: a clinical randomized study with use of aprotease inhibitor. Hepatogastroenterology. 2007; 54: 2055-2060.
15. Shimoda M, Iwasaki Y, Sawada T, Kubota K. Protective effect of ischemic preconditioning against liver injury after major hepatectomy using the intermittent Pringle maneuver in swine. Pathobiology. 2007; 74: 42-49.
16. Scatton O, Zalinski S, Jegou D, et al. Randomized clinical trial of ischemic preconditioning in major liver resection with intermittent Pringle maneuver. Br J Surg. 2011; 98: 1236-1243.
17. Petrowsky H, McCormack L, Trujillo M, et al. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg. 2006; 244: 921-928.
18. Gurusamy KS, Sheth H, Kumar Y, et al. WITHDRAWN: methods of vascular occlusion for elective liver resections. Cochrane Database Syst Rev. 2009: CD006409.
19. Man K, Ng KT, Lo CM, et al. Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases-activation of cell invasion and migration pathways. Liver Transpl. 2007; 13: 1669-1677.
20. Man K, Lo CM, Xiao JW, et al. The significance of acute phase small-for-size graft injury on tumor growth and invasiveness after liver transplantation. Ann Surg. 2008; 247: 1049-1057.
21. Ozaki M, Todo S. Surgical stress and tumor behavior: impact of ischemia reperfusion and hepatic resection on tumor progression. Liver Transpl. 2007; 13: 1623-1626.
22. Doi K, Horiuchi T, Uchinami M, et al. Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res. 2002; 105: 243-247.
23. Doi K, Horiuchi T, Uchinami M, et al. Neutrophil elastase inhibitor reduces hepatic metastases induced by ischaemia-reperfusion in rats. Eur J Surg. 2002; 168: 507-510.
24. Van der Bilt JD, Soeters ME, Duyverman AM, et al. Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Am J Pathol. 2007; 170: 1379-1388.
25. Van der Bilt JD, Kranenburg O, Nijkamp MW, et al. Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology. 2005; 42: 165-175.
26. Van der Bilt JD, Kranenburg O, Borren A, et al. Ageing and hepatic steatosis exacerbate ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Ann Surg Oncol. 2008; 15: 1392-1398.
27. Yoshida M, Horiuchi T, Uchinami M, et al. Intermittent hepatic ischemia-reperfusion minimizes liver metastasis in rats. J Surg Res. 2003; 111: 255-260.
28. Kurata M, Okajima K, Kawamoto T, et al. Antithrombin reduces reperfusion-induced hepatic metastasis of colon cancer cells. World J Gastroenterol. 2006; 12: 60-65.
29. Nicoud IB, Jones CM, Pierce JM, et al. Warm hepatic ischemiareperfusion promotes growth of colorectal carcinoma micrometastases in mouse liver via matrix metalloproteinase-9 induction. Cancer Res. 2007; 67: 2720-2728.
30. Yoshimoto K, Tajima H, Ohta T, et al. Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancer. Oncol Rep. 2012; 28: 791-796.
31. Tamagawa K, Horiuchi T, Uchinami M, et al. Hepatic ischemiareperfusion increases vascular endothelial growth factor and cancer growth in rats. J Surg Res. 2008; 148: 158-163.
32. Lim C, Broqueres-You D, Brouland JP, et al. Hepatic ischemiareperfusion increases circulating bone marrow-derived progenitor cells and tumor growth in a mouse model of colorectal liver metastases. J Surg Res. 2013; 184: 888-897.
33. Eguchi S, Kanematsu T, Arii S, et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery. 2008; 143: 469-475.
34. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg. 2009; 250: 177-186.
35. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in. J Hepatol. 2008; 48(Suppl 1): S20-37.
36. Gurusamy KS, Pamecha V, Sharma D, Davidson BR. Techniques for liver parenchymal transection in liver resection. Cochrane Database Syst Rev. 2009: CD006880.
37. Huang J, Hernandez-Alejandro R, Croome KP, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1, 061 cases. J Gastrointest Surg. 2011; 15: 311-320.
38. Bilt van der JD, Livestro DP, Borren A, et al. European survey on the application of vascular clamping in liver surgery. Dig Surg. 2007; 24: 423-435.
39. Torzilli G, Procopio F, Donadon M, et al. Safety of intermittent Pringle maneuver cumulative time exceeding 120 minutes in liver resection: a further step in favor of the "radical but conservative" policy. Ann Surg. 2012; 255: 270-280.
40. Radojkovic M, Stojanovic M, Stanojevic G, et al. Intermittent or continuous occlusion of hepatic inflow. Bratisl Lek Listy. 2013; 114: 3-6.
41. De Boer MT, Molenaar IQ, Porte RJ. Impact of blood loss on outcome after liver resection. Dig Surg. 2007; 24: 259-264.
42. Kooby DA, Stockman J, Ben-Porat L, et al. Influence of transfusions on perioperative and long-term outcome in patients following hepatic resection for colorectal metastases. Ann Surg. 2003; 237: 860-869.
43. Katz SC, Shia J, Liau KH, et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg. 2009; 249: 617-623.
44. Liu L, Wang Z, Jiang S, et al. Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One. 2013; 8: e64261.
45. Hanazaki K, Kajikawa S, Shimozawa N, et al. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma. Hepatogastroenterology. 2005; 52: 524-529.
46. Weiss MJ, Ito H, Araujo RL, et al. Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence. Ann Surg Oncol. 2013; 20: 285-294.
47. Giuliante F, Ardito F, Pulitanò C, et al. Does hepatic pedicle clamping affect disease-free survival following liver resection for colorectal metastases? Ann Surg. 2010; 252: 1020-1026.
48. Wong KH, Hamady ZZ, Malik HZ, et al. Intermittent Pringle manoeuvre is not associated with adverse long-term prognosis after resection for colorectal liver metastases. Br J Surg. 2008; 95: 985-989.
49. Matsuda A, Miyashita M, Matsumoto S, et al. Hepatic pedicle clamping does not worsen survival after hepatic resection for colorectal liver metastasis: results from a systematic review and meta-analysis. Ann Surg Oncol. 2013; 20: 3771-3778.
50. Ferrero A, Russolillo N, Vigano L, et al. Does Pringle maneuver affect survival in patients with colorectal liver metastases? World J Surg. 2010; 34: 2418-2425.
51. Ishizuka M, Kubota K, Kita J, et al. Duration of hepatic vascular inflow clamping and survival after liver resection for hepatocellular carcinoma. Br J Surg. 2011; 98: 1284-1290.
52. Xia F, Lau WY, Xu Y, et al. Does hepatic ischemia-reperfusion injury induced by hepatic pedicle clamping affect survival after partial hepatectomy for hepatocellular carcinoma? World J Surg. 2013; 37: 192-201.
53. Gurusamy KS, Sheth H, Kumar Y, et al. Methods of vascular occlusion for elective liver resections. Cochrane Database Syst Rev. 2009: CD007632.
54. O'Neill S, Leuschner S, McNally SJ, et al. Meta-analysis of ischaemic preconditioning for liver resections. Br J Surg. 2013; 100: 1689-1700.